Loading clinical trials...
Loading clinical trials...
The purpose of this study is to develop a clinical understanding of early liver transplantation (ELT) for patients with severe alcoholic hepatitis (SAH) and identify the public's opinion regarding this practice.
The research study is designed to improve the investigators' understanding of early liver transplantation for patients with severe alcoholic hepatitis. The goal of this research is twofold: 1. Establish a knowledge base necessary for appropriate liver transplant candidate selection by quantifying post-ELT mortality for SAH and compare to outcomes to liver transplantation for other indications 2. Develop an ethical framework for implementation of these transplants for SAH based on the opinions of healthcare providers and the general public.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Johns Hopkins University
Baltimore, Maryland, United States
Start Date
April 1, 2020
Primary Completion Date
December 31, 2028
Completion Date
December 31, 2029
Last Updated
December 16, 2025
300
ESTIMATED participants
liver transplant
PROCEDURE
Lead Sponsor
Johns Hopkins University
Collaborators
NCT06493773
NCT06950788
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions